‘… Even Accountants Don’t Dream In PowerPoints And T-Accounts’: Report From The Inaugural Irish Accounting And Finance Association Learning And Teaching Day M Healy, E Doyle, H McBride, P Buckley, M Farrell Accounting, Finance & Governance Review 26 (1), 2020 | | 2020 |
‘Horse trading’: prescribing injectable opiates to opiate addicts. A descriptive study M Battersby, M Farrell, M Gossop, P Robson, J Strang Drug and Alcohol Review 11 (1), 35-42, 1992 | 62 | 1992 |
‘I just thought that was the best thing for me to do at this point’: Exploring patient experiences with depot buprenorphine and their motivations to discontinue S Clay, C Treloar, L Degenhardt, J Grebely, M Christmass, C Gough, ... International Journal of Drug Policy 115, 104002, 2023 | 9 | 2023 |
‘Synthetic cannabis’: A dangerous misnomer S Darke, S Banister, M Farrell, J Duflou, J Lappin International Journal of Drug Policy 98, 103396, 2021 | 19 | 2021 |
‘The lesser of two evils’: A qualitative study of staff and client experiences and beliefs about addressing tobacco in addiction treatment settings AJ Wilson, B Bonevski, A Dunlop, A Shakeshaft, F Tzelepis, S Walsberger, ... Drug and Alcohol Review 35 (1), 92-101, 2016 | 27 | 2016 |
" Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: A systematic review and meta-analysis": Correction. N Black, E Stockings, G Campbell, LT Tran, D Zagic, WD Hall, M Farrell, ... Elsevier Science, 2020 | | 2020 |
" Clinical features of patients attending a gender-identity clinic": Reply. A Burns, M Farrell, J Christie-Brown Royal College of Psychiatrists, 1991 | | 1991 |
" Our Maggie M Farrell BMJ 299, 21, 1989 | | 1989 |
" WE'VE HAD A CIRCUIT BREAKER FOR AN OLD DOGMA OF MORE THAN 20 YEARS": CHANGES TO OPIOID AGONIST TREATMENT SERVICES DURING COVID-19, THE CHOICE STUDY A Conway, C Treloar, S Crawford, L Degenhardt, GJ Dore, M Farrell, ... Drug and Alcohol Review, S59-S59, 2021 | | 2021 |
“You'll come in and dose even in a global pandemic”: A qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemic A Conway, C Treloar, S Crawford, L Degenhardt, GJ Dore, M Farrell, ... International Journal of Drug Policy 114, 103998, 2023 | 8 | 2023 |
1 Australian Criminal Intelligence Commission (ACIC), Illicit drug data report, 2021, online. 2 ACIC, Illicit drug data report, 2020, online. 3 ACIC, National Wastewater Drug … L Degenhardt, M Farrell | | |
1.6 Health Utility Among People Who Regularly Use Opioids in Australia: A Cross-Sectional Survey in Three Australian Jurisdictions AD Tran, J Grebely, M Chambers, L Degenhardt, M Farrell, B Larance 2023 World Congress on Health Economics, 2023 | | 2023 |
184 Radiotherapy AC Parrott, RS Murphy, CD Rosenbaum, SP Carreiro, KM Babu, ... Medical Toxicology 8 (1), 15-32, 2015 | | 2015 |
1p19q co-deleted oligodendroglioma metastatic to bone J Greene, K Cadoo, J Ti, N O'Donnell, D Allcutt, M Farrell, L Grogan Clinical neuropathology 32 (2), 139-141, 2013 | 4 | 2013 |
22 anorexia nervosa, bulimia nervosa, and Eating Disorders VK Ekvall, SW Ekvall, M Farrell, A DALIA Pediatric and Adult Nutrition in Chronic Diseases, Developmental …, 2017 | | 2017 |
35 Gastrointestinal Disorders of Infancy and Childhood M FARRELL, A CASSIN, R WILHELM Pediatric and Adult Nutrition in Chronic Diseases, Developmental …, 2017 | | 2017 |
4. Substance misuse among white and black/mixed race female prisoners M Farrell, T Barnes, R Burnett, S Miller, D Briggs Prisoners’ drug use and treatment: seven research studies, 49, 2003 | 23 | 2003 |
5. and the Family DPA Conflict, AS Model, MA Fine, LA Kurdek, NL Galambos, DM Almeida, ... Book Reviews 994, 995, 0 | | |
9.2 Individual treatment: theoretical and practical approaches M FARRELL, J STRANG Psychiatry for the Developing World, 177, 1996 | | 1996 |
96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial M Farrell, J Shahbazi, M Chambers, M Byrne, J Gholami, E Zahra, ... International Journal of Drug Policy 127, 104390, 2024 | | 2024 |